2022 Event Guide

The Allogeneic Cell Therapies Summit is the leading industry-dedicated meeting that considers pre-clinical development, translation, manufacturing, supply and storage of allogeneic cell therapies to improve the accessibility and efficacy of patient care worldwide.

300+ experts from pharma, biotech and leading academia attended in Boston next May 2022 to uncover best-in-class approaches to overcome.

Join the movement to revolutionize a universal cell therapy!

Allo FC 1

Having trouble downloading the brochure? Let us know here and we’ll email it to you instead.

Hear What Previous Attendees Have to Say;

“The Allogeneic Cell Therapies Summit greatly covered the landscape of the field with outstanding presentations and discussions.”
CSO, Pluto

“Very informative summit with lots of great material, knowledgeable and engaging speakers and overall a fantastic experience.”
Non-clinical Safety Lead, Johnson & Johnson

“This was a very nice event. The focus on Allogeneic was really good and this summit provided an opportunity to have a more holistic view of the field and its potential. Very well done!”
Chief Operations Officer, Celyad

“The Allogeneic Cell Therapies Summit highlighted key advances and outstanding challenges of what remains a very much ‘up and coming’ and rapidly evolving arm of immunotherapy.”
Associate Director, Allogeneic Development, Triumvira Immunologics

“The quality of the presentations and diverse topics covered within the allogeneic cell therapy field were top notch.”
Senior Scientist, Immatics